Developer docs
API playgroundTry for free, no card

Search company profiles

The Macula Foundation Inc

Full company profile

uuid00yp51d

Namestring
The Macula Foundation Inc
Legal namestring
The Macula Foundation, Inc.
Company typeenum
Private
Founded yearint
1978
Descriptiontext

The Macula Foundation, Inc. is a New York-based non-profit founded in 1978, established as the first organization in the world dedicated exclusively to macula disease research. Its mission is the prevention and restoration of vision loss due to macular disease, with a primary focus on age-related macular degeneration (AMD), diabetic retinopathy, central serous chorioretinopathy, and related retinal conditions. The foundation operates through a research, teaching, and public awareness model — funding studies, training the next generation of retinal specialists via fellowships, and convening scientific meetings such as the Atlantic Coast Retinal Club/Macula Symposium.

The foundation's core technical assets are its research output and affiliated institutional network. It supports diagnostic and therapeutic innovation including OCT Angiography, Enhanced Depth Imaging, the Pachychoroid disease classification, and the development of anti-VEGF medications such as MACUGEN. It maintains a searchable archive of over 600 peer-reviewed scientific publications and co-authored The Retinal Atlas, the most widely distributed textbook in ophthalmology. The foundation partners with Manhattan Eye, Ear & Throat Hospital (Northwell Health), NYU, and Columbia University for fellowship training and the operations of the LuEsther T. Mertz Retinal Research Center.

The foundation's revenue model is charitable donations from individuals, including online, phone, mail, and stock donations, with stock donations processed through Morgan Stanley Private Wealth Management. Funding is directed toward research grants, fellowships, and educational programming. Its primary beneficiaries are patients with macular disease (especially AMD and diabetic retinopathy) and the medical professionals and researchers who serve them. The foundation is led by President Lawrence A. Yannuzzi, MD, with a board that includes financial and medical leaders, and it operates with a small staff of 1-10 employees.

Short descriptiontext

The Macula Foundation, Inc. is a New York-based non-profit founded in 1978 and the first organization dedicated exclusively to macula disease research. It funds research, trains retinal specialists through fellowships, and publishes peer-reviewed work, primarily serving patients with macular disease and the ophthalmic research community.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
macular disease research, ophthalmology research funding, retinal disease research, ophthalmology fellowship programs, vision loss prevention
Industry1 code
1Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryYes
NAICS code1 code
  • Grantmaking Foundations813211
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Ophthalmology Research and Education
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Grants
TypeOthers
Description

The foundation raises and distributes funds for research and teaching in macular disease. Revenue comes from donations made by individuals, including online donations, phone donations, mail-in checks, and stock donations.

maculafoundation.org
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Others, Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

The Macula Foundation, Inc. is a non-profit research foundation that raises and distributes funds for research and teaching in macular disease. It funds innovative research into age-related macular degeneration (AMD), diabetic retinopathy, central serous chorioretinopathy, and related retinal conditions, while training the next generation of retinal specialists through fellowship programs at affiliated institutions and disseminating knowledge through publications and conferences.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Discovery of Anti-VEGF medications for wet macular degeneration treatment
+3 more records
Product overview1 text field

The Macula Foundation is a non-profit research organization devoted exclusively to discoveries and research in macula disease. It offers a publications archive of over 600 scientific publications, supports fellowship training programs, and facilitates donations. The foundation does not operate commercial software products but provides research resources, educational materials, and grant funding for macular disease research.

Product and service5 records
1Publications Archive
CategoryResearch Resource
Description

A searchable collection of over 600 scientific publications within the ophthalmic community, featuring contributions by members of The Macula Foundation. Supports search by title, topic, author, PMID, PMCID, and DOI. Available to researchers, physicians, and the public.

2Fellowship Programs
CategoryEducational Program
Description

Training programs for physicians in the macular disease field, including Medical Retina Fellows and International Research Fellows, with affiliations at institutions including Columbia University, NYU, and Manhattan Eye, Ear & Throat Hospital.

3Research Funding
CategoryGrant Program
Description

The Foundation has raised and distributed over $50 million for research and teaching in macular disease, supporting discoveries in age-related macular degeneration, diabetic retinopathy, central serous chorioretinopathy, and other retinal diseases.

4Donation Processing
CategorySupport Service
Description

Online donation platform allowing secure contributions to The Macula Foundation, with options for tribute or memorial gifts, stock donations, and phone/mail donations.

5Recent Publications
CategoryResearch Resource
Description

Featured recent scientific publications supported by The Macula Foundation, covering topics in age-related macular degeneration, diabetic retinopathy, retinal imaging, and various macular diseases.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Over 40-year relationship with Manhattan Eye, Ear & Throat Hospital. Foundation supports the LuEsther T. Mertz Research Center at the hospital. Joint fellowship programs with Columbia University and NYU for training retinal specialists.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

50+ year relationship with NYU bringing in fellows at national level. Foundation hosts one of the largest meetings of retinal specialists worldwide, The Atlantic Coast Retinal Club/Macula Symposium, at Farkas Auditorium NYU School of Medicine.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

40+ year retinal fellowship relationship with Columbia University supporting collaborative research within the Retinal Department. Fellows receive retinal experience and training over two years.

Strategic tierMinorTypeOthers
Description

Stock donation processing partner. James J Bell serves as Executive Director overseeing stock donations to the foundation at Morgan Stanley Private Wealth Management, 1585 Broadway New York, NY 10036.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

U.S. federal institute within NIH that funds and conducts vision research. Comparable as a major funder of macular disease research, though funded by government appropriations rather than donations.

TypeDirect peer
Description

A non-profit foundation funding retinal disease research and offering grants, fellowships, and scientific conferences. Directly comparable as a vision-focused research grantmaking foundation with overlapping donor pool and investigator network.

TypeDirect peer
Description

Largest volunteer eye health and safety organization in the U.S., funding vision research and public awareness. Comparable in fundraising channels, public-awareness mission, and ophthalmic research grants.

TypeDirect peer
Description

Non-profit dedicated exclusively to AMD awareness, research, and support. Closest pure-play peer in macular disease focus and donor-driven revenue model.

TypeEmerging player
Description

International society of retinal specialists focused on macular disease research and education. Comparable in disease focus, conference programming (e.g., Gass Award), and physician-network model.

TypeDirect peer
Description

Global umbrella organization for national retina-focused charities supporting research and patient advocacy. Comparable in retina disease focus and international researcher/fellow network.

TypeDirect peer
Description

Funds research on macular degeneration, glaucoma, and Alzheimer's disease through grants and public education. Comparable in mission, donation-driven revenue model, and grantmaking focus on macular degeneration.

TypeBroad incumbent
Description

Largest global eye and vision research organization, hosting major conferences and publishing journals. Comparable as a convening organization for vision researchers, though broader in scope than macular-specific work.

TypeDirect peer
Description

Provides research grants to vision science departments at U.S. ophthalmic institutions. Directly comparable grantmaking model and affiliation-based funding approach targeting the same institutional and donor ecosystem.

TypeEmerging player
Description

Non-profit funding glaucoma-specific research and physician training. Comparable in disease-specific grantmaking and fellowship support, but focuses on glaucoma rather than macular disease.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Macula Foundation Inc

Ophthalmology Research and Educationmaculafoundation.org

The Macula Foundation, Inc. is a New York-based non-profit founded in 1978 and the first organization dedicated exclusively to macula disease research. It funds research, trains retinal specialists through fellowships, and publishes peer-reviewed work, primarily serving patients with macular disease and the ophthalmic research community.

What The Macula Foundation Inc does

The Macula Foundation, Inc. is a New York-based non-profit founded in 1978, established as the first organization in the world dedicated exclusively to macula disease research. Its mission is the prevention and restoration of vision loss due to macular disease, with a primary focus on age-related macular degeneration (AMD), diabetic retinopathy, central serous chorioretinopathy, and related retinal conditions. The foundation operates through a research, teaching, and public awareness model — funding studies, training the next generation of retinal specialists via fellowships, and convening scientific meetings such as the Atlantic Coast Retinal Club/Macula Symposium.

The foundation's core technical assets are its research output and affiliated institutional network. It supports diagnostic and therapeutic innovation including OCT Angiography, Enhanced Depth Imaging, the Pachychoroid disease classification, and the development of anti-VEGF medications such as MACUGEN. It maintains a searchable archive of over 600 peer-reviewed scientific publications and co-authored The Retinal Atlas, the most widely distributed textbook in ophthalmology. The foundation partners with Manhattan Eye, Ear & Throat Hospital (Northwell Health), NYU, and Columbia University for fellowship training and the operations of the LuEsther T. Mertz Retinal Research Center.

The foundation's revenue model is charitable donations from individuals, including online, phone, mail, and stock donations, with stock donations processed through Morgan Stanley Private Wealth Management. Funding is directed toward research grants, fellowships, and educational programming. Its primary beneficiaries are patients with macular disease (especially AMD and diabetic retinopathy) and the medical professionals and researchers who serve them. The foundation is led by President Lawrence A. Yannuzzi, MD, with a board that includes financial and medical leaders, and it operates with a small staff of 1-10 employees.

The Macula Foundation Inc firmographics

Firmographics
Name
The Macula Foundation Inc
Legal name
The Macula Foundation, Inc.
Website
https://maculafoundation.org
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
1–10 employees
Short description
The Macula Foundation, Inc. is a New York-based non-profit founded in 1978 and the first organization dedicated exclusively to macula disease research. It funds research, trains retinal specialists through fellowships, and publishes peer-reviewed work, primarily serving patients with macular disease and the ophthalmic research community.
Ownership category
akta.pro rank

The Macula Foundation Inc industry classification

Industry
Product category
Ophthalmology Research and Education
NAICS
Grantmaking Foundations (813211)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Research & Science Grantmaking Foundations (BPAGAKAI)

Keywords

  • Macular disease research
  • Ophthalmology research funding
  • Retinal disease research
  • Ophthalmology fellowship programs
  • Vision loss prevention

Where The Macula Foundation Inc is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The Macula Foundation Inc business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Others, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Donations and Grants: The foundation raises and distributes funds for research and teaching in macular disease. Revenue comes from donations made by individuals, including online donations, phone donations, mail-in checks, and stock donations.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

The Macula Foundation Inc product offering

Product offering

Core offering

The Macula Foundation, Inc. is a non-profit research foundation that raises and distributes funds for research and teaching in macular disease. It funds innovative research into age-related macular degeneration (AMD), diabetic retinopathy, central serous chorioretinopathy, and related retinal conditions, while training the next generation of retinal specialists through fellowship programs at affiliated institutions and disseminating knowledge through publications and conferences.

Product overview

The Macula Foundation is a non-profit research organization devoted exclusively to discoveries and research in macula disease. It offers a publications archive of over 600 scientific publications, supports fellowship training programs, and facilitates donations. The foundation does not operate commercial software products but provides research resources, educational materials, and grant funding for macular disease research.

Differentiator

Problem solved

Functional benefit

Products and services

  • Publications Archive A searchable collection of over 600 scientific publications within the ophthalmic community, featuring contributions by members of The Macula Foundation. Supports search by title, topic, author, PMID, PMCID, and DOI. Available to researchers, physicians, and the public.
  • Fellowship Programs Training programs for physicians in the macular disease field, including Medical Retina Fellows and International Research Fellows, with affiliations at institutions including Columbia University, NYU, and Manhattan Eye, Ear & Throat Hospital.
  • Research Funding The Foundation has raised and distributed over $50 million for research and teaching in macular disease, supporting discoveries in age-related macular degeneration, diabetic retinopathy, central serous chorioretinopathy, and other retinal diseases.
  • Donation Processing Online donation platform allowing secure contributions to The Macula Foundation, with options for tribute or memorial gifts, stock donations, and phone/mail donations.
  • Recent Publications Featured recent scientific publications supported by The Macula Foundation, covering topics in age-related macular degeneration, diabetic retinopathy, retinal imaging, and various macular diseases.

Quantifiable outcome

  • Discovery of Anti-VEGF medications for wet macular degeneration treatment
  • +3 more outcomes

Companies that use The Macula Foundation Inc

Customer profile

Segments2 records

Ideal customer profiles2 records

The Macula Foundation Inc technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

The Macula Foundation Inc partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Manhattan Eye, Ear & Throat Hospital (Northwell Health)coreStrategic or Co-development PartnerOver 40-year relationship with Manhattan Eye, Ear & Throat Hospital. Foundation supports the LuEsther T. Mertz Research Center at the hospital. Joint fellowship programs with Columbia University and NYU for training retinal specialists.
  • New York University (NYU)coreStrategic or Co-development Partner50+ year relationship with NYU bringing in fellows at national level. Foundation hosts one of the largest meetings of retinal specialists worldwide, The Atlantic Coast Retinal Club/Macula Symposium, at Farkas Auditorium NYU School of Medicine.
  • Columbia UniversitycoreStrategic or Co-development Partner40+ year retinal fellowship relationship with Columbia University supporting collaborative research within the Retinal Department. Fellows receive retinal experience and training over two years.
  • Morgan Stanley Private Wealth ManagementminorOthersStock donation processing partner. James J Bell serves as Executive Director overseeing stock donations to the foundation at Morgan Stanley Private Wealth Management, 1585 Broadway New York, NY 10036.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

The Macula Foundation Inc competitors and assessment

Company assessment

Broad incumbents

  • National Eye Institute (NEI): U.S. federal institute within NIH that funds and conducts vision research. Comparable as a major funder of macular disease research, though funded by government appropriations rather than donations.
  • Association for Research in Vision and Ophthalmology (ARVO): Largest global eye and vision research organization, hosting major conferences and publishing journals. Comparable as a convening organization for vision researchers, though broader in scope than macular-specific work.

Direct peers

  • Foundation Fighting Blindness: A non-profit foundation funding retinal disease research and offering grants, fellowships, and scientific conferences. Directly comparable as a vision-focused research grantmaking foundation with overlapping donor pool and investigator network.
  • Prevent Blindness: Largest volunteer eye health and safety organization in the U.S., funding vision research and public awareness. Comparable in fundraising channels, public-awareness mission, and ophthalmic research grants.
  • American Macular Degeneration Foundation: Non-profit dedicated exclusively to AMD awareness, research, and support. Closest pure-play peer in macular disease focus and donor-driven revenue model.
  • Retina International: Global umbrella organization for national retina-focused charities supporting research and patient advocacy. Comparable in retina disease focus and international researcher/fellow network.
  • BrightFocus Foundation: Funds research on macular degeneration, glaucoma, and Alzheimer's disease through grants and public education. Comparable in mission, donation-driven revenue model, and grantmaking focus on macular degeneration.
  • Research to Prevent Blindness: Provides research grants to vision science departments at U.S. ophthalmic institutions. Directly comparable grantmaking model and affiliation-based funding approach targeting the same institutional and donor ecosystem.

Emerging players

  • The Macula Society: International society of retinal specialists focused on macular disease research and education. Comparable in disease focus, conference programming (e.g., Gass Award), and physician-network model.
  • Glaucoma Research Foundation: Non-profit funding glaucoma-specific research and physician training. Comparable in disease-specific grantmaking and fellowship support, but focuses on glaucoma rather than macular disease.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

The Macula Foundation Inc social profiles

Digital presence

The Macula Foundation Inc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Macula Foundation Inc leadership team

Management profile

Number of profiles

Profiles10 records

The Macula Foundation Inc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Macula Foundation Inc M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Macula Foundation Inc

What does The Macula Foundation Inc do?

The Macula Foundation, Inc. is a non-profit research foundation that raises and distributes funds for research and teaching in macular disease. It funds innovative research into age-related macular degeneration (AMD), diabetic retinopathy, central serous chorioretinopathy, and related retinal conditions, while training the next generation of retinal specialists through fellowship programs at affiliated institutions and disseminating knowledge through publications and conferences.

Is The Macula Foundation Inc a public or private company?

The Macula Foundation Inc is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The Macula Foundation Inc founded?

The Macula Foundation Inc was founded in 1978. It employs 1 to 10 people.

Where is The Macula Foundation Inc based?

The Macula Foundation Inc is headquartered in New York, United States, in the North America region.

How does The Macula Foundation Inc make money?

One revenue line is on record: donations and Grants.

Who are The Macula Foundation Inc's main competitors?

Broad incumbents on record are National Eye Institute (NEI) and Association for Research in Vision and Ophthalmology (ARVO). Direct peers are Foundation Fighting Blindness, Prevent Blindness, American Macular Degeneration Foundation, Retina International, BrightFocus Foundation and Research to Prevent Blindness. Emerging players are The Macula Society and Glaucoma Research Foundation.

Does The Macula Foundation Inc have an API?

No public API is recorded for The Macula Foundation Inc.

What industry is The Macula Foundation Inc in?

The Macula Foundation Inc's product category is Ophthalmology Research and Education. Its primary akta.pro industry code is BPAGAKAI, Research & Science Grantmaking Foundations. Its NAICS code is 813211 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales